
Aditya Shreenivas, MD, MS, discusses the clinical trial that led to the FDA approval of penpulimab in nasopharyngeal carcinoma.

Your AI-Trained Oncology Knowledge Connection!

Aditya Shreenivas, MD, MS, is an assistant professor in the Department of Medical Oncology & Therapeutics Research at City of Hope.